What is unique about the LEAN drugs (Lidocaine, Epinephrine, Atropine, Naloxone)?

• A. They are the only drugs that can be given through ETT
• B. They are the only drugs used in pediatric resuscitation
• C. They are the only drugs given intranasally
• D. They are the only drugs given IV/IO

Answer: (A)

The key idea is that these four drugs are the ones still considered appropriate to give through the endotracheal tube when IV or IO access isn’t available. In emergency pediatric resuscitation, establishing IV/IO access can be time‑consuming or difficult, so the endotracheal route provides a rapid fallback. Lidocaine, epinephrine, atropine, and naloxone are grouped together because guidelines specify them as suitable for ET administration and because their formulations and absorption via the airway give more predictable delivery via this route than many other drugs.

That’s why this set is unique: they have established endotracheal dosing pathways, whereas many other drugs are designed for IV/IO use or alternative routes (like intranasal) and aren’t singled out as ET‑route options. The other choices aren’t correct because they either overstate how narrow the use is (not only these drugs are used in pediatric resuscitation), or imply routes (intranasal, IV/IO as the only route) that don’t capture the specific ET‑administration distinction of LEAN drugs.